Ujang Purnama is currently a PhD student in Department of Physiology, Anatomy, and Genetics, University of Oxford. Ujang is working on a project exploring the utilization of induced pluripotent stem cells (iPSC) for disease modeling, drug targeting, and regenerative medicine. Ujang's research interest is in studying engineered heart tissue (EHT) from induced pluripotent stem cell-derived cardiomyocytes for diabetic cardiomyopathy disease model and drug repurposing.
Ujang received Bachelor’s degree in Pharmaceutical Science and Technology from Bandung Institute of Technology in 2015, where he was also trained as a licensed pharmacist in Indonesia. During undergraduate study, He undertook an internship at Sumitomo Chemical Company, Japan, to study embryonic stem cell differentiation to cardiomyocytes and neuron cell for toxicology testing. In 2015, he joined Dr. Leonie Beljaars’s lab as an intern at University Medical Centre Groningen, the Netherlands, to study the effects of engineered human interferon gamma on vascular smooth muscle cell.